136 related articles for article (PubMed ID: 32369413)
1. Utility of Routine Surveillance Laboratory Testing in Detecting Relapse in Patients With Classic Hodgkin Lymphoma in First Remission: Results From a Large Single-Institution Study.
Lynch RC; Sundaram V; Desai M; Henry S; Wood D; Daadi S; Hoppe RT; Advani R
JCO Oncol Pract; 2020 Sep; 16(9):e902-e911. PubMed ID: 32369413
[TBL] [Abstract][Full Text] [Related]
2. Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission.
Hawkes EA; Loh Z; Estacio O; Chong G; Ha FJ; Gilbertson M; Grigg A
Br J Cancer; 2018 Aug; 119(5):546-550. PubMed ID: 30033446
[TBL] [Abstract][Full Text] [Related]
3. Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs.
El-Galaly TC; Mylam KJ; Brown P; Specht L; Christiansen I; Munksgaard L; Johnsen HE; Loft A; Bukh A; Iyer V; Nielsen AL; Hutchings M
Haematologica; 2012 Jun; 97(6):931-6. PubMed ID: 22207683
[TBL] [Abstract][Full Text] [Related]
4. Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
El-Galaly TC; Mylam KJ; Bøgsted M; Brown P; Rossing M; Gang AO; Haglund A; Arboe B; Clausen MR; Jensen P; Pedersen M; Bukh A; Jensen BA; Poulsen CB; d'Amore F; Hutchings M
Am J Hematol; 2014 Jun; 89(6):575-80. PubMed ID: 24493389
[TBL] [Abstract][Full Text] [Related]
5. Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission.
Truong Q; Shah N; Knestrick M; Curley B; Hu Y; Craig M; Hamadani M
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):50-5. PubMed ID: 24119465
[TBL] [Abstract][Full Text] [Related]
6. Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.
Picardi M; Pugliese N; Cirillo M; Zeppa P; Cozzolino I; Ciancia G; Pettinato G; Salvatore C; Quintarelli C; Pane F
Radiology; 2014 Jul; 272(1):262-74. PubMed ID: 24708193
[TBL] [Abstract][Full Text] [Related]
7. Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission.
Pingali SR; Jewell SW; Havlat L; Bast MA; Thompson JR; Eastwood DC; Bartlett NL; Armitage JO; Wagner-Johnston ND; Vose JM; Fenske TS
Cancer; 2014 Jul; 120(14):2122-9. PubMed ID: 24711253
[TBL] [Abstract][Full Text] [Related]
8. Relapse after treatment of pediatric Hodgkin lymphoma: outcome and role of surveillance after end of therapy.
Friedmann AM; Wolfson JA; Hudson MM; Weinstein HJ; Link MP; Billett A; Larsen EC; Yock T; Donaldson SS; Marcus K; Krasin MJ; Howard SC; Metzger ML
Pediatr Blood Cancer; 2013 Sep; 60(9):1458-63. PubMed ID: 23677874
[TBL] [Abstract][Full Text] [Related]
9. Hodgkin lymphoma patients in first remission: routine positron emission tomography/computerized tomography imaging is not superior to clinical follow-up for patients with no residual mass.
Dann EJ; Berkahn L; Mashiach T; Frumer M; Agur A; McDiarmid B; Bar-Shalom R; Paltiel O; Goldschmidt N
Br J Haematol; 2014 Mar; 164(5):694-700. PubMed ID: 24313286
[TBL] [Abstract][Full Text] [Related]
10. Effect of Routine Surveillance Imaging on the Outcomes of Patients With Classical Hodgkin Lymphoma After Autologous Hematopoietic Cell Transplantation.
Kapke JT; Epperla N; Shah N; Richardson K; Carrum G; Hari PN; Pingali SR; Hamadani M; Karmali R; Fenske TS
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17(7):408-414. PubMed ID: 28756899
[TBL] [Abstract][Full Text] [Related]
11. Patients' and physicians' roles in detecting recurrent Hodgkin lymphoma following complete remission.
Bestawros A; Foltz L; Srour N; Savage KJ; Connors JM
Ann Oncol; 2013 May; 24(5):1359-63. PubMed ID: 23230136
[TBL] [Abstract][Full Text] [Related]
12. Pediatric Burkitt's lymphoma and diffuse B-cell lymphoma: are surveillance scans required?
Eissa HM; Allen CE; Kamdar K; Simko S; Goradia P; Dreyer Z; Steuber P; McClain KL; Guillerman RP; Bollard CM
Pediatr Hematol Oncol; 2014 Apr; 31(3):253-7. PubMed ID: 24087880
[TBL] [Abstract][Full Text] [Related]
13. Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy.
Cheah CY; Dickinson M; Hofman MS; George A; Ritchie DS; Prince HM; Westerman D; Harrison SJ; Burbury K; Wolf M; Januszewicz H; Herbert KE; Carney DA; Tam C; Seymour JF
Ann Hematol; 2014 Jul; 93(7):1193-200. PubMed ID: 24595733
[TBL] [Abstract][Full Text] [Related]
14. Surveillance imaging of Hodgkin lymphoma patients in first remission: a clinical and economic analysis.
Lee AI; Zuckerman DS; Van den Abbeele AD; Aquino SL; Crowley D; Toomey C; Lacasce AS; Feng Y; Neuberg DS; Hochberg EP
Cancer; 2010 Aug; 116(16):3835-42. PubMed ID: 20564135
[TBL] [Abstract][Full Text] [Related]
15. Surveillance imaging during first remission in follicular lymphoma does not impact overall survival.
Goldman ML; Mao JJ; Strouse CS; Chen W; Rupji M; Chen Z; Maurer MJ; Calzada O; Churnetski M; Flowers CR; Cerhan JR; Link BK; Thompson CA; Cohen JB
Cancer; 2021 Sep; 127(18):3390-3402. PubMed ID: 34157780
[TBL] [Abstract][Full Text] [Related]
16. The role of routine imaging procedures in the detection of relapse of patients with Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.
Goldschmidt N; Or O; Klein M; Savitsky B; Paltiel O
Ann Hematol; 2011 Feb; 90(2):165-71. PubMed ID: 20706721
[TBL] [Abstract][Full Text] [Related]
17. Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group.
Voss SD; Chen L; Constine LS; Chauvenet A; Fitzgerald TJ; Kaste SC; Slovis T; Schwartz CL
J Clin Oncol; 2012 Jul; 30(21):2635-40. PubMed ID: 22689804
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of routine surveillance with positron emission tomography/computed tomography in aggressive non-Hodgkin lymphoma in complete remission: status in a single center.
El-Galaly T; Prakash V; Christiansen I; Madsen J; Johansen P; Boegsted M; Johnsen HE; Bukh A
Leuk Lymphoma; 2011 Apr; 52(4):597-603. PubMed ID: 21314488
[TBL] [Abstract][Full Text] [Related]
19. Routine Blood Tests in Asymptomatic Patients With Indolent Lymphoma Have Limited Ability to Detect Clinically Significant Disease Progression.
Piercey OA; Loh Z; Chan J; Chong G; Grigg A; Cheema S; Gill G; Whybird M; Cushion T; Hawkes EA
JCO Oncol Pract; 2020 Nov; 16(11):e1315-e1323. PubMed ID: 32584701
[TBL] [Abstract][Full Text] [Related]
20. Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma.
Hill M; Cunningham D; MacVicar D; Roldan A; Husband J; McCready R; Mansi J; Milan S; Hickish T
J Clin Oncol; 1993 Nov; 11(11):2273-8. PubMed ID: 8229142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
